Latest

Mar 07, 2018
Pharmaceutical Executive
Markus Warmuth, CEO of cancer genomics company H3 Biomedicine, speaks with Pharm Exec about being part of a new wave of biotech business leaders, who let the science chart the course.
Mar 07, 2018
Pharmaceutical Executive
How one pharma vet helped create the first industry-wide training standards for aspiring medical affairs professionals. 
Mar 06, 2018
Pharmaceutical Executive
Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma’s pricing playbook are explored.
Mar 02, 2018
For companies that overcome the challenges, there is tremendous opportunity to drive sustainable growth through technology and analytics-driven business innovation, writes Vita Cassese.
Mar 01, 2018
Pharmaceutical Executive
Innovations in consumer genetic health are rapidly advancing—and pharma commercial thinking needs to catch up.
Mar 01, 2018
Jin Zhang outlines four key areas that impacted Chinese pharma in 2017 and looks at how their effects will shape the industry in the years ahead.
Feb 26, 2018
Adhering to new compliance legislation such as Identification of Medicinal Products (IDMP) can bring a pharma company benefits as well as challenges, writes Darren Cooper.
Feb 20, 2018
Scott Beauchamp discussed the future of analytics in the life sciences industry—and look at how peers in other industries have reaped the benefits of being early movers.
Feb 14, 2018
Advocates on all sides applauded the request to increase funding significantly for FDA under the Trump administration’s budget for fiscal year 2019.
Feb 12, 2018
Pharm Exec speaks to Jane Griffiths, Global Head of Actelion, about the current state of the industry's reputation and the work that needs to be done to further build trust with patients and the public.
native1_300x100
lorem ipsum